These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9083626)

  • 1. The impact of red cell substitutes on the blood service in Japan.
    Sekiguchi S
    Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):53-60. PubMed ID: 9083626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood components: indication and notice of transfusion].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology, economics, and the business of blood.
    Carter TH
    Biotechnology; 1991; 19():3-30. PubMed ID: 1786473
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV retrospective study of the German Red Cross blood donation service in Germany].
    Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Report on notifications pursuant to Section 21 German Transfusion Act for 2007].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):715-31. PubMed ID: 19572110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a national disaster on blood supply and safety: the September 11 experience.
    Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH;
    JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa.
    Erhabor O; Adias TC
    Transfus Clin Biol; 2011 Dec; 18(5-6):516-26. PubMed ID: 22037104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of autologous blood collection and transfusion in Japan in 1997.
    Ohto H; Fuji T; Wakimoto N; Anan M; Maeda H
    Transfus Sci; 2000; 22(1-2):13-8. PubMed ID: 10771374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of detection of novel human parvoviruses in German plasma donations.
    Eis-Hübinger AM; Drexler JF; Reber U; Panning M; Drosten C; Weber-Schehl M; Hedges D; Baylis SA; Roth WK
    Transfusion; 2010 Jan; 50(1):266-7. PubMed ID: 20233349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risk of disease transmission via donor blood in Denmark at the turn of the century].
    Dickmeiss E; Christiansen AH; Smith E
    Ugeskr Laeger; 2001 May; 163(19):2628-32. PubMed ID: 11360356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The annual cost of blood transfusions in the United Kingdom.
    Guest JF; Munro V; Cookson RF
    Clin Lab Haematol; 1998 Apr; 20(2):111-8. PubMed ID: 9681222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
    Taira R; Satake M; Momose S; Hino S; Suzuki Y; Murokawa H; Uchida S; Tadokoro K
    Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report on Notifications pursuant to Section 21 German Transfusion Act for 2001 and 2002].
    Haschberger B; Waterkamp A; Heiden M; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Jan; 48(1):99-119. PubMed ID: 15650911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk management in blood transfusion services.
    Whyte G
    Vox Sang; 1998; 74 Suppl 2():105-9. PubMed ID: 9704431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan.
    Asai T; Inaba S; Ohto H; Osada K; Suzuki G; Takahashi K; Tadokoro K; Minami M
    Transfus Med; 2000 Dec; 10(4):315-20. PubMed ID: 11123816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for safer and more appropriate use of blood transfusion systems in Japan].
    Sagawa K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):7-12. PubMed ID: 15696692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.